19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Extracellular vesicles enclosed‐miR‐421 suppresses air pollution (PM 2.5)‐induced cardiac dysfunction via ACE2 signalling

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Air pollution, via ambient PM 2.5, is a big threat to public health since it associates with increased hospitalisation, incidence rate and  mortality of cardiopulmonary injury. However, the potential mediators of pulmonary injury in PM 2.5‐induced cardiovascular disorder are not fully understood. To investigate a potential cross talk between lung and heart upon PM 2.5 exposure, intratracheal instillation in vivo, organ culture ex vivo and human bronchial epithelial cells (Beas‐2B) culture in vitro experiments were performed respectively. The exposed supernatants of Beas‐2B were collected to treat primary neonatal rat cardiomyocytes (NRCMs). Upon intratracheal instillation, subacute PM 2.5 exposure caused cardiac dysfunction, which was time‐dependent secondary to lung injury in mice, thereby demonstrating a cross‐talk between lungs and heart potentially mediated via small extracellular vesicles (sEV). We isolated sEV from PM 2.5‐exposed mice serum and Beas‐2B supernatants to analyse the change of sEV subpopulations in response to PM 2.5. Single particle interferometric reflectance imaging sensing analysis (SP‐IRIS) demonstrated that PM 2.5 increased CD63/CD81/CD9 positive particles. Our results indicated that respiratory system‐derived sEV containing miR‐421 contributed to cardiac dysfunction post‐PM 2.5 exposure. Inhibition of miR‐421 by AAV9‐miR421‐sponge could significantly reverse PM 2.5‐induced cardiac dysfunction in mice. We identified that cardiac angiotensin converting enzyme 2 (ACE2) was a downstream target of sEV‐miR421, and induced myocardial cell apoptosis and cardiac dysfunction. In addition, we observed that GW4869 (an inhibitor of sEV release) or diminazene aceturate (DIZE, an activator of ACE2) treatment could attenuate PM 2.5‐induced cardiac dysfunction in vivo. Taken together, our results suggest that PM 2.5 exposure promotes sEV‐linked miR421 release after lung injury and hereby contributes to PM 2.5‐induced cardiac dysfunction via suppressing ACE2.

          Related collections

          Most cited references67

          • Record: found
          • Abstract: found
          • Article: not found

          The biology, function, and biomedical applications of exosomes

          The study of extracellular vesicles (EVs) has the potential to identify unknown cellular and molecular mechanisms in intercellular communication and in organ homeostasis and disease. Exosomes, with an average diameter of ~100 nanometers, are a subset of EVs. The biogenesis of exosomes involves their origin in endosomes, and subsequent interactions with other intracellular vesicles and organelles generate the final content of the exosomes. Their diverse constituents include nucleic acids, proteins, lipids, amino acids, and metabolites, which can reflect their cell of origin. In various diseases, exosomes offer a window into altered cellular or tissue states, and their detection in biological fluids potentially offers a multicomponent diagnostic readout. The efficient exchange of cellular components through exosomes can inform their applied use in designing exosome-based therapeutics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.

            ACE2, the first known human homologue of angiotensin-converting enzyme (ACE), was identified from 5' sequencing of a human heart failure ventricle cDNA library. ACE2 has an apparent signal peptide, a single metalloprotease active site, and a transmembrane domain. The metalloprotease catalytic domains of ACE2 and ACE are 42% identical, and comparison of the genomic structures indicates that the two genes arose through duplication. In contrast to the more ubiquitous ACE, ACE2 transcripts are found only in heart, kidney, and testis of 23 human tissues examined. Immunohistochemistry shows ACE2 protein predominantly in the endothelium of coronary and intrarenal vessels and in renal tubular epithelium. Active ACE2 enzyme is secreted from transfected cells by cleavage N-terminal to the transmembrane domain. Recombinant ACE2 hydrolyzes the carboxy terminal leucine from angiotensin I to generate angiotensin 1-9, which is converted to smaller angiotensin peptides by ACE in vitro and by cardiomyocytes in culture. ACE2 can also cleave des-Arg bradykinin and neurotensin but not bradykinin or 15 other vasoactive and hormonal peptides tested. ACE2 is not inhibited by lisinopril or captopril. The organ- and cell-specific expression of ACE2 and its unique cleavage of key vasoactive peptides suggest an essential role for ACE2 in the local renin-angiotensin system of the heart and kidney. The full text of this article is available at http://www. circresaha.org.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              RNA delivery by extracellular vesicles in mammalian cells and its applications

              The term ‘extracellular vesicles’ refers to a heterogeneous population of vesicular bodies of cellular origin that derive either from the endosomal compartment (exosomes) or as a result of shedding from the plasma membrane (microvesicles, oncosomes and apoptotic bodies). Extracellular vesicles carry a variety of cargo, including RNAs, proteins, lipids and DNA, which can be taken up by other cells, both in the direct vicinity of the source cell and at distant sites in the body via biofluids, and elicit a variety of phenotypic responses. Owing to their unique biology and roles in cell–cell communication, extracellular vesicles have attracted strong interest, which is further enhanced by their potential clinical utility. Because extracellular vesicles derive their cargo from the contents of the cells that produce them, they are attractive sources of biomarkers for a variety of diseases. Furthermore, studies demonstrating phenotypic effects of specific extracellular vesicle-associated cargo on target cells have stoked interest in extracellular vesicles as therapeutic vehicles. There is particularly strong evidence that the RNA cargo of extracellular vesicles can alter recipient cell gene expression and function. During the past decade, extracellular vesicles and their RNA cargo have become better defined, but many aspects of extracellular vesicle biology remain to be elucidated. These include selective cargo loading resulting in substantial differences between the composition of extracellular vesicles and source cells; heterogeneity in extracellular vesicle size and composition; and undefined mechanisms for the uptake of extracellular vesicles into recipient cells and the fates of their cargo. Further progress in unravelling the basic mechanisms of extracellular vesicle biogenesis, transport, and cargo delivery and function is needed for successful clinical implementation. This Review focuses on the current state of knowledge pertaining to packaging, transport and function of RNAs in extracellular vesicles and outlines the progress made thus far towards their clinical applications.
                Bookmark

                Author and article information

                Contributors
                junjiexiao@shu.edu.cn
                Journal
                J Extracell Vesicles
                J Extracell Vesicles
                10.1002/(ISSN)2001-3078
                JEV2
                Journal of Extracellular Vesicles
                John Wiley and Sons Inc. (Hoboken )
                2001-3078
                10 May 2022
                May 2022
                : 11
                : 5 ( doiID: 10.1002/jev2.v11.5 )
                : e12222
                Affiliations
                [ 1 ] Institute of Geriatrics (Shanghai University) Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong) School of Medicine Shanghai University Nantong China
                [ 2 ] Cardiac Regeneration and Ageing Lab Institute of Cardiovascular Sciences Shanghai Engineering Research Center of Organ Repair School of Life Science Shanghai University Shanghai China
                [ 3 ] Institute for Immunology Tsinghua University Beijing China
                [ 4 ] China‐America Institute Neuroscience Beijing Luhe Hospital, Capital Medical University Beijing China
                [ 5 ] Cardiovascular Division of the Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA
                [ 6 ] CDL Research University Medical Center Utrecht Utrecht The Netherlands
                [ 7 ] Department of Cardiology Laboratory of Experimental Cardiology University Medical Center Utrecht Utrecht The Netherlands
                [ 8 ] UMC Utrecht Regenerative Medicine Center University Medical Center Utrecht University Utrecht The Netherlands
                Author notes
                [*] [* ] Correspondence

                Prof. Junjie Xiao Cardiac Regeneration and Ageing lab, Institute of Cardiovascular Sciences, Shanghai Engineering Research Center of Organ Repair, School of Life Science, Shanghai University, 333 Nan Chen Road, Shanghai 200444, China.

                Email: junjiexiao@ 123456shu.edu.cn

                Author information
                https://orcid.org/0000-0003-2417-5924
                https://orcid.org/0000-0002-9202-0003
                Article
                JEV212222
                10.1002/jev2.12222
                9089227
                35536587
                ccf703ce-25c7-47d1-be17-2e60d8ed6f0f
                © 2022 The Authors. Journal of Extracellular Vesicles published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 03 April 2022
                : 14 October 2021
                : 15 April 2022
                Page count
                Figures: 6, Tables: 0, Pages: 20, Words: 11866
                Funding
                Funded by: National Key Research and Development Project
                Award ID: 2018YFE0113500
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Award ID: 82020108002
                Award ID: 81911540486
                Award ID: 82000253
                Award ID: 81600008
                Funded by: Science and Technology Commission of Shanghai Municipality , doi 10.13039/501100003399;
                Award ID: 20DZ2255400
                Award ID: 21XD1421300
                Funded by: the “Dawn” Program of Shanghai Education Commission
                Award ID: 19SG34
                Funded by: the Sailing Program from Science and Technology Commission of Shanghai
                Award ID: 20YF1414000
                Funded by: “Chenguang Program” of Shanghai Education Development Foundation and Shanghai Municipal Education Commission
                Award ID: 20CG46
                Funded by: Horizon2020 ERC‐2016‐COG EVICARE
                Award ID: 725229
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                May 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.5 mode:remove_FC converted:10.05.2022

                pm2.5,cardiac dysfunction,extracellular vesicles,mir‐421,ace2

                Comments

                Comment on this article